The economic cost of delirium : A systematic review and quality assessment
© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association..
INTRODUCTION: This review aims to systematically identify and appraise the methodological quality of claims on the cost of delirium; and discuss challenges and opportunities for improvements in the precision of the estimates.
METHODS: Searches of scientific papers and gray literature were performed up until June 2020. The Larg and Moss checklist was used to assess the methodological quality of the included studies.
RESULTS: After deduplication, the search identified 317 potentially relevant articles, of which 17 articles were eligible for inclusion. After adjusting for inflation and common currency, the cost of delirium ranged between $806 and $24,509 (in 2019 US$).
DISCUSSION: This review found significant variation among the cost estimates and methodological quality. There has been limited focus on dementia as a sequela of delirium in terms of economic implications, but recent evidence suggests cost implications of delirium may be 52% higher when dementia is considered.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Alzheimer's & dementia : the journal of the Alzheimer's Association - 17(2021), 6 vom: 06. Juni, Seite 1026-1041 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kinchin, Irina [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cost |
---|
Anmerkungen: |
Date Completed 12.11.2021 Date Revised 12.11.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/alz.12262 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320424359 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320424359 | ||
003 | DE-627 | ||
005 | 20231225173543.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/alz.12262 |2 doi | |
028 | 5 | 2 | |a pubmed24n1068.xml |
035 | |a (DE-627)NLM320424359 | ||
035 | |a (NLM)33480183 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kinchin, Irina |e verfasserin |4 aut | |
245 | 1 | 4 | |a The economic cost of delirium |b A systematic review and quality assessment |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.11.2021 | ||
500 | |a Date Revised 12.11.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association. | ||
520 | |a INTRODUCTION: This review aims to systematically identify and appraise the methodological quality of claims on the cost of delirium; and discuss challenges and opportunities for improvements in the precision of the estimates | ||
520 | |a METHODS: Searches of scientific papers and gray literature were performed up until June 2020. The Larg and Moss checklist was used to assess the methodological quality of the included studies | ||
520 | |a RESULTS: After deduplication, the search identified 317 potentially relevant articles, of which 17 articles were eligible for inclusion. After adjusting for inflation and common currency, the cost of delirium ranged between $806 and $24,509 (in 2019 US$) | ||
520 | |a DISCUSSION: This review found significant variation among the cost estimates and methodological quality. There has been limited focus on dementia as a sequela of delirium in terms of economic implications, but recent evidence suggests cost implications of delirium may be 52% higher when dementia is considered | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a cost | |
650 | 4 | |a cost of illness | |
650 | 4 | |a delirium | |
650 | 4 | |a economic impact | |
650 | 4 | |a methodology | |
650 | 4 | |a quality assessment | |
650 | 4 | |a systematic review | |
700 | 1 | |a Mitchell, Eileen |e verfasserin |4 aut | |
700 | 1 | |a Agar, Meera |e verfasserin |4 aut | |
700 | 1 | |a Trépel, Dominic |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Alzheimer's & dementia : the journal of the Alzheimer's Association |d 2005 |g 17(2021), 6 vom: 06. Juni, Seite 1026-1041 |w (DE-627)NLM168942356 |x 1552-5279 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2021 |g number:6 |g day:06 |g month:06 |g pages:1026-1041 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/alz.12262 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2021 |e 6 |b 06 |c 06 |h 1026-1041 |